It has been reported that MTX treatment can induce Immunogenic Cell Death (ICD) melanoma, osteosarcoma, and mouse colon cancer cells, acting through an eIF2α phosphorylation-dependent mechanism [24, 25]. Here, EIF2A is linked to malignant colon neoplasm.